Jext (Epinephrine Bitartrate)

Epinephrine activates alpha‑ and beta‑adrenergic receptors. Alpha‑1 stimulation causes blood vessels to constrict, raising blood pressure and reducing swelling. Beta‑1 activation increases heart rate and contractility, while beta‑2 activation relaxes bronchial smooth muscle, leading to bronchodilation. These combined effects reverse the critical symptoms of anaphylaxis.

The dose of Jext is determined by the prescribing clinician based on the patient’s age, weight, and severity of the reaction. Healthcare professionals follow established guidelines and adjust the amount and frequency of intramuscular injection as needed for each individual case.

The safety of epinephrine in pregnancy and lactation has not been definitively established. It should only be used when the potential benefit outweighs any possible risk to the mother or fetus. Clinicians should evaluate each situation carefully and consider alternative treatments when appropriate.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and the necessary import documentation.

Jext’s active ingredient, epinephrine, is the first‑line treatment for anaphylaxis and is considered the most effective option for rapid reversal of symptoms. Other agents, such as antihistamines or corticosteroids, may be used as adjuncts but do not provide the immediate vasoconstrictive and bronchodilatory actions that epinephrine delivers.

Jext should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. If temporary exposure to higher temperatures occurs, the product should be inspected for any changes before use, and manufacturers’ guidelines should be followed.

Jext is administered by intramuscular injection, typically into the anterolateral thigh. The injection should be given promptly at the first sign of a severe allergic reaction, using aseptic technique. Training on proper administration is essential for healthcare providers and patients who may need to self‑inject.

Serious risks include cardiac arrhythmias, severe hypertension, myocardial ischemia, and pulmonary edema. Rarely, tissue necrosis can occur at the injection site. Immediate medical evaluation is required if any of these severe reactions are observed after administration.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any component of the formulation. Caution is advised for patients with certain cardiovascular disorders, uncontrolled hypertension, or hyperthyroidism, and it should be avoided in patients taking non‑selective beta‑blockers without medical supervision.